INS and Hyperglycemia: When low doses of streptozotocin were administered to SGLT2−/− and Sweet Pee mice to create a diabetes model via impaired insulin secretion, hyperglycemia was improved in both cases, but mortality was reported to be increased in Sweet Pee compared to wild-type mice.